Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
NewsPartner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. OSCR
stocks logo

OSCR

-
Add to WatchlistAdvanced Chart
$
0.000
0(0.000%)1D
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q4
FY2026Q1
3.08B
+27.05%
-0.628
+185.38%
3.03B
+26.47%
-1.070
+72.6%
2.84B
-6.92%
0.357
-61.23%
Estimates Revision
The market is revising Upward the revenue expectations for Oscar Health, Inc. (OSCR) for FY2025, with the revenue forecasts being adjusted by 7.08% over the past three months. During the same period, the stock price has changed by -7.19%.
Revenue Estimates for FY2025
Revise Upward
up Image
+7.08%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-291.67%
In Past 3 Month
Stock Price
Go Down
down Image
-7.19%
In Past 3 Month
8 Analyst Rating
down Image0
Wall Street analysts forecast OSCR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for OSCR is 11.29 USD with a low forecast of 8.00 USD and a high forecast of 14.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
3 Hold
5 Sell
Moderate Sell
down Image0
Current: 15.610
sliders
Low
8.00
Averages
11.29
High
14.00
down Image0
Current: 15.610
sliders
Low
8.00
Averages
11.29
High
14.00
Baird
Outperform -> Neutral
downgrade
$28 -> $14
2025-07-25
Reason
Baird
Price Target
$28 -> $14
2025-07-25
downgrade
Outperform -> Neutral
Reason
Baird downgraded Oscar Health to Neutral from Outperform with a price target of $14, down from $28. The firm cites its caution on the healthcare exchange end market for the downgrade. Given Oscar's recent pre-announced Q2 and 2025 outlook revision, Baird is increasingly cautious into 2026 and beyond. There is now significant complexity in projecting Oscar's risk adjustment revenue, the analyst tells investors in a research note.
Baird
Outperform -> Neutral
downgrade
$28 -> $14
2025-07-24
Reason
Baird
Price Target
$28 -> $14
2025-07-24
downgrade
Outperform -> Neutral
Reason
Baird downgraded Oscar Health to Neutral from Outperform with a price target of $14, down from $28.
Barclays
Underweight
downgrade
$17 -> $11
2025-07-23
Reason
Barclays
Price Target
$17 -> $11
2025-07-23
downgrade
Underweight
Reason
Barclays lowered the firm's price target on Oscar Health to $11 from $17 and keeps an Underweight rating on the shares. The firm reduced estimates through 2027 following the earnings report.
UBS
Neutral -> Sell
downgrade
$15 -> $11
2025-07-15
Reason
UBS
Price Target
$15 -> $11
2025-07-15
downgrade
Neutral -> Sell
Reason
UBS downgraded Oscar Health to Sell from Neutral with a price target of $11, down from $15. The firm believes recent developments in the public health insurance exchanges create uncertainty that is not fully priced into the shares. UBS expects Oscar's exchange enrollment to fall at least 30% in 2026 when enhanced subsidies expire. The company will be unable to offset the membership loss with pricing, the analyst tells investors in a research note.
Wells Fargo
Equal Weight -> Underweight
downgrade
$16 -> $10
2025-07-11
Reason
Wells Fargo
Price Target
$16 -> $10
2025-07-11
downgrade
Equal Weight -> Underweight
Reason
Wells Fargo downgraded Oscar Health to Underweight from Equal Weight with a price target of $10, down from $16.
Wells Fargo
Equal Weight -> Underweight
downgrade
$16 -> $10
2025-07-11
Reason
Wells Fargo
Price Target
$16 -> $10
2025-07-11
downgrade
Equal Weight -> Underweight
Reason
Wells Fargo downgraded Oscar Health to Underweight from Equal Weight with a price target of $10, down from $16. The firm says evidence of rising exchange acuity continues to build for Oscar. Exchange commentary from almost all public plans in Q1 was concerning, the analyst tells investors in a research note. Wells believes 2025 pricing is not adequate to cover cost trends and increasing market acuity. Oscar Health's visibility could remain low for some time, the firm contends.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Oscar Health Inc (OSCR.N) is -11.94, compared to its 5-year average forward P/E of 29.78. For a more detailed relative valuation and DCF analysis to assess Oscar Health Inc 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
29.78
Current PE
-11.94
Overvalued PE
96.04
Undervalued PE
-36.47

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
1.22
Current EV/EBITDA
-48.71
Overvalued EV/EBITDA
10.69
Undervalued EV/EBITDA
-8.25

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.51
Current PS
0.34
Overvalued PS
1.04
Undervalued PS
-0.02

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

OSCR News & Events

Events Timeline

(ET)
2025-08-07
16:58:04
Mixed options sentiment in Oscar Health with shares up 5.75%
select
2025-08-06 (ET)
2025-08-06
06:22:03
Oscar Health reports Q2 EPS (89c), consensus (84c)
select
2025-07-29 (ET)
2025-07-29
12:40:10
Mixed options sentiment in Oscar Health with shares down 3.92%
select
Sign Up For More Events
Sign Up For More Events

News

Preview
9.5
08-07NASDAQ.COM
Oscar Health (OSCR) Q2 Revenue Rises 29%

  • Financial Performance: Oscar Health reported a 29% year-over-year revenue increase to $2.86 billion, but faced a GAAP net loss of $228.4 million due to a high medical loss ratio of 91.1%, which indicates rising healthcare costs and unfavorable risk adjustments.

  • Membership Growth and Future Outlook: Despite operational challenges, Oscar Health's membership grew by 28% to over 2 million, primarily in individual and small group plans; the company maintains its full-year guidance for fiscal 2025, anticipating market stabilization and a return to profitability by 2026.

Preview
7.0
08-07SeekingAlpha
Oscar Health outlines $12B–$12.2B 2025 revenue target and new ICHRA strategy amid market reset

  • Financial Performance: Oscar Health reported a 29% increase in total revenue to $2.9 billion for Q2 2025, but faced a loss from operations of $230 million and an adjusted EBITDA loss of $199 million, while reaffirming its revenue guidance for 2025 between $12 billion and $12.2 billion.

  • Strategic Adjustments: The company is addressing increased market morbidity through rate adjustments, cost reductions, and strategic acquisitions, aiming for profitability by 2026 despite current challenges in the ACA marketplace.

Preview
7.0
08-06Benzinga
Oscar Health Well-Positioned To Manage Market Reset, Eyes Profitability In 2026

  • Financial Performance: Oscar Health Inc. reported second-quarter revenue of approximately $2.86 billion, missing estimates, with a net loss of $228.36 million and an operating loss of $230.5 million, while membership increased to 2.03 million.

  • Future Outlook: CEO Mark Bertolini expressed confidence in the individual market's long-term potential, reaffirming fiscal 2025 sales guidance of $12 billion to $12.2 billion, despite challenges leading to expected losses.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Oscar Health Inc (OSCR) stock price today?

The current price of OSCR is 15.61 USD — it has increased 0.97 % in the last trading day.

arrow icon

What is Oscar Health Inc (OSCR)'s business?

Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.

arrow icon

What is the price predicton of OSCR Stock?

Wall Street analysts forecast OSCR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for OSCR is 11.29 USD with a low forecast of 8.00 USD and a high forecast of 14.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Oscar Health Inc (OSCR)'s revenue for the last quarter?

Oscar Health Inc revenue for the last quarter amounts to 2.86B USD, increased 29.04 % YoY.

arrow icon

What is Oscar Health Inc (OSCR)'s earnings per share (EPS) for the last quarter?

Oscar Health Inc. EPS for the last quarter amounts to -0.89 USD, decreased -594.44 % YoY.

arrow icon

What changes have occurred in the market's expectations for Oscar Health Inc (OSCR)'s fundamentals?

The market is revising Upward the revenue expectations for Oscar Health, Inc. (OSCR) for FY2025, with the revenue forecasts being adjusted by 7.08% over the past three months. During the same period, the stock price has changed by -7.19%.
arrow icon

How many employees does Oscar Health Inc (OSCR). have?

Oscar Health Inc (OSCR) has 2400 emplpoyees as of August 12 2025.

arrow icon

What is Oscar Health Inc (OSCR) market cap?

Today OSCR has the market capitalization of 4.04B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free